Evidence map›Paper›PMID 34373593›Full record

ArticleScientific reports2021

Fabrication and characterization of scaffolds containing different amounts of allantoin for skin tissue engineering.

Yeganeh Dorri Nokoorani, Amir Shamloo, Maedeh Bahadoran, Hamideh Moravvej

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Fabrication of BioactiveACS omega · 2024
    Article
  16. Article
  17. TurningBiomedicines · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yeganeh Dorri NokooraniMechanical Engineering Department, Sharif University of Technology, Tehran, Iran.
Amir ShamlooMechanical Engineering Department, Sharif University of Technology, Tehran, Iran. shamloo@sharif.edu.
Maedeh BahadoranMechanical Engineering Department, Sharif University of Technology, Tehran, Iran.
Hamideh MoravvejSkin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. hamidehmoravej@sbmu.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using the skin tissue engineering approach is a way to help the body to recover its lost skin in cases that the spontaneous healing process is either impossible or inadequate, such as severe wounds or burns. In the present study, chitosan/gelatin-based scaffolds containing 0.25, 0.5, 0.75, and 1% allantoin were created to improve the wounds' healing process. EDC and NHS were used to cross-link the samples, which were further freeze-dried. Different in-vitro methods were utilized to characterize the specimens, including SEM imaging, PBS absorption and degradation tests, mechanical experiments, allantoin release profile assessment, antibacterial assay, and cell viability and adhesion tests. The results indicated that the scaffolds' average pore sizes were approximately in the range of 390-440 µm, and their PBS uptake amounts were about 1000% to 1250% after being soaked in PBS for 24 h. Around 70% of the specimens were degraded in 6 days, but they were not fully degraded after 21 days. Besides, the samples showed antibacterial activity against S. aureus and E. coli bacteria. In general, the MTT cell viability test indicated that the cells' density increased slightly or remained the same during the experiment. SEM images of cells seeded on the scaffolds indicated appropriate properties of the scaffolds for cell adhesion.

Indexed as

AllantoinAnimalsAnti-Bacterial AgentsBiocompatible MaterialsCell AdhesionCell LineCell SurvivalChitosanEscherichia coliGelatinHumansMaterials TestingMiceMicroscopy, Electron, ScanningPorosityRegenerative MedicineAllantoinAnti-Bacterial AgentsBiocompatible MaterialsChitosanGelatin

Identifiers

PMID34373593
PMCPMC8352935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.